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Summary
Background In sub-Saharan Africa, community-acquired bacteraemia is an important cause of illness and death in 
children. Our aim was to establish the magnitude and causes of hospital-acquired (nosocomial) bacteraemia in 
African children.
Methods We reviewed prospectively collected surveillance data of 33 188 admissions to Kiliﬁ  District Hospital, Kenya, 
between April 16, 2002, and Sept 30, 2009. We deﬁ ned bacteraemia as nosocomial if it occurred 48 h or more after 
admission. We estimated the per-admission risk, daily rate, eﬀ ect on mortality, and microbial cause of nosocomial 
bacteraemia and analysed risk factors by multivariable Cox regression. The eﬀ ect on morbidity was measured as the 
increase in hospital stay by comparison with time-matched patients without bacteraemia.
Findings The overall risk of nosocomial bacteraemia during this period was 5·9/1000 admissions (95% CI 5·2–6·9) 
but we recorded an underlying rise in risk of 27% per year. The incidence was 1·0/1000 days in hospital (0·87–1·14), 
which is about 40 times higher than that of community-acquired bacteraemia in the same region. Mortality in patients 
with nosocomial bacteraemia was 53%, compared with 24% in community-acquired bacteraemia and 6% in patients 
without bacteraemia. In survivors, nosocomial bacteraemia lengthened hospital stay by 10·1 days (3·0–17·2). Klebsiella 
pneumoniae, Escherichia coli, Staphylococcus aureus, Acinetobacter spp, group D streptococci, and Pseudomonas 
aeruginosa accounted for three-quarters of nosocomial infections. Nosocomial bacteraemia was signiﬁ cantly associated 
with severe mal nutrition (hazard ratio 2·52, 95% CI 1·79–3·57) and blood transfusion in children without severe 
anaemia (4·99; 3·39–7·37).
Interpretation Our ﬁ ndings show that although nosocomial bacteraemia is rare, it has serious eﬀ ects on morbidity 
and mortality, and the microbiological causes are distinct from those of community-acquired bacteraemia. Nosocomial 
infections are largely unrecog nised or undocumented as a health risk in low-income countries, but they are likely to 
become public health priorities as awareness of their occurrence increases and as other prominent childhood diseases 
are progressively controlled.
Funding Wellcome Trust.
Introduction
“Health-care-associated infection in developing 
countries is a serious issue that is scarcely addressed in 
the scientiﬁ c literature”.1 In sub-Saharan Africa, 
community-acquired paediatric bacteraemia imposes a 
major health burden.2–6 However, almost no regional 
information is available about hospital-acquired 
(nosocomial) bacteraemia. The WHO Patient Safety 
programme7 did a systematic review of health-care-
associated infection in developing countries between 
1995 and 2008 and found no reports about nosocomial 
bacteraemia in adults or children in Africa, and only ﬁ ve 
studies of paediatric nosocomial bacteraemia from 
developing countries worldwide. A review focusing on 
infections in hospital-born neonates suggested a high 
risk of disease in this age group across the region.8 
Untreated maternal HIV infection is an important risk 
factor for neonatal nosocomial sepsis.9 Outbreak 
reports10–12 show that this disease occurs in the region 
but do not provide the denominator data necessary for 
estimation of risk or incidence.
We aimed to assess the risk, rate, eﬀ ect on mortality 
and morbidity, microbiological causes, and risk factors 
for paediatric nosocomial bacteraemia by analysing 
surveillance data obtained prospectively for a continuous 
period at one Kenyan hospital.
Methods
Study design and patients
Kiliﬁ  District Hospital is in a rural area in Coast Province 
of Kenya. The Kenya Medical Research Institute-
Wellcome Trust Research Programme has undertaken 
surveillance for invasive bacterial disease in children 
admitted to this hospital for more than a decade. Further 
information about Kiliﬁ  District Hospital is available in 
the webappendix. Throughout the analysis period 
between April 16, 2002, and Sept 30, 2009, we obtained 
specimens from all paediatric inpatients (except those 
with minor trauma or undergoing elective surgery) to 
investigate clinical illness both on admission and during 
the hospital stay. All children (except those described 
above) admitted to the paediatric ward were investigated 
See Online for webappendix
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with blood cultures on admission. We systematically 
obtained detailed clinical and laboratory information 
from all patients at admission. We used WHO standard 
techniques to take anthropometric measurements and 
we calculated weight-for-age Z scores using American 
National Centre for Health Statistics reference data.
We investigated patients with persistent or new fever, 
or clinical deterioration after admission, with a septic 
screen consisting of blood cultures, urine testing, and 
other samples as clinically indicated. Blood samples were 
taken by the admitting clinician, or by a ward aide (ie, 
a clinical support worker with phlebotomy training) after 
cleansing of the child’s skin with 70% alcohol. Blood was 
inoculated into a culture bottle (BACTEC Peds Plus, 
Becton Dickinson, Franklin Lakes, NJ, USA) after the top 
of the bottle had been disinfected. We used an automated 
culturing system (BACTEC 9050, Becton Dickinson) to 
process blood cultures. We subcultured positive samples 
onto standard media and used standard microbiological 
techniques to identify the micro organisms. Laboratory 
procedures were internally controlled, and quality was 
monitored externally by the UK National External Quality 
Assessment Service. The monthly performance score for 
culturing of simulated specimens and identiﬁ cation of 
test organisms was higher than 95%.
Our study included an analysis of bacterial surveillance 
data that were drawn from two studies of invasive bacterial 
diseases at Kiliﬁ  District Hospital. Parents or guardians of 
all patients gave written informed consent for participation 
in these studies, which included cultures of blood taken 
at admission and routine investigations of clinical care. 
Both studies were approved by the Kenya Medical 
Research Institute National Ethics Review Committee.
Case deﬁ nition
We deﬁ ned an episode of nosocomial bacteraemia as 
isolation of a pathogenic organism (bacterial or fungal) 
from the blood of a child when the sample was taken 
more than 48 h after admission. We classiﬁ ed bacter-
aemia on readmission (within 28 days of discharge or 
hospital birth) as health-care-associated and all other 
positive blood cultures as community acquired. We 
regarded repeated isolation of the same pathogen in 
blood cultures within 14 days as one disease episode, 
whereas we regarded isolation of a diﬀ erent pathogen 
as a dis tinct disease episode. Coagulase-negative 
staphylococci, Bacillus spp, Micrococcus spp, viridans 
group streptococci, and coryneform bacteria were 
regarded as contaminants.
Statistical analysis
We did analyses in STATA version 11.0. We calculated the 
risk of at least one episode of nosocomial bacteraemia 
per admission and the incidence per 1000 days of 
inpatient hospital stay. We used log-linear binomial 
regression to characterise trends in the yearly risk of 
nosocomial bacteraemia and the probability of identifying 
a pathogen if a blood sample for culture had been taken. 
We analysed change in duration of hospital stay by year 
using Cox regression.
We used multivariable Cox regression to investigate 
the association of risk factors with the development of 
nosocomial bacteraemia. This approach is independent 
of length of hospital stay and is suitable for analysis of 
nosocomial infections in inpatient cohort data13 even if 
the outcome is rare.14 We used adjustment of variance 
for clustering within individuals with several 
admissions, and log-log plots for each variable to 
graphically conﬁ rm the validity of the proportional 
hazards assumption. We converted risk factor data, 
originally recorded in continuous variables, to binary or 
categorical variables before examining the eﬀ ects of 
risk factors. Variables were included in a multivariable 
model if they showed a univariate association of p<0·1. 
We tested for interactions between biologically 
associated variables in the ﬁ nal model.
To produce unbiased estimates of the additional length 
of hospital stay attributable to nosocomial bacteraemia, 
we used a confounder and time matching approach.15 
When possible, we randomly selected four patients who 
survived to discharge without nosocomial bacteraemia 
and matched by age and nutritional status to a patient 
with nosocomial bacteraemia, with the further constraint 
that they had been in hospital at least as long as the index 
patient at the point he or she developed bacteraemia. With 
an assumed mean hospital stay of 20 days (SD 25 days) in 
unexposed patients, matching of four patients to each 
case provides more than 90% power to detect an increased 
duration of 10 days in the exposed group.
Role of the funding source
The sponsors of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. The corresponding author had full 
access to all the data in the study and had ﬁ nal 
responsibility for the decision to submit for publication.
Results
35 143 admissions were made to Kiliﬁ  District Hospital in 
the study period, of which 1316 (4%) were excluded 
because no blood was taken for culture, and 639 (2%) 
were excluded because of missing data or errors in 
the dates of admission or discharge. We analysed 
33 188 admissions (94%) in 26 721 patients.
The median length of hospital stay was 3·7 days 
(IQR 2·0–6·8 days) and the median age at admission 
was 1·3 years (range 0 days to 15 years, IQR 157 days to 
3·0 years). About 14% of the children admitted were 
neonates (age ≤28 days, table 1), though the proportion 
increased from 11% (904 of 8547) in 2002–03 to 18% 
(1219 of 6889) in 2008–09.
We identiﬁ ed 212 episodes of nosocomial bacteraemia. 
13 children had two episodes and one child had three 
episodes during the same admission, so the total number 
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of admissions with at least one episode of nosocomial 
bacteraemia was 197. Most episodes of nosocomial 
bacteraemia were preceded by one or more negative 
blood cultures (88%, 186 of 212) or by an admission blood 
culture isolating a diﬀ erent pathogen (5%, 11 of 212), 
supporting the inference of hospital-acquired disease. 
The risk of development of nosocomial bacteraemia at 
least once during a hospital stay was 5·9 per 
1000 admissions (95% CI 5·2–6·9).
We included 212 933 inpatient days of observation in the 
study period, giving an overall rate of nosocomial 
bacteraemia of 1·00 episode per 1000 person-days 
(0·87–1·14) or 36 340 episodes per 100 000 person-years 
(31 777–41 639). In children younger than 2 years 
at admission, the rate was 42 398 episodes per 
100 000 person-years (36 222–49 626). The estimated 
incidence of community-acquired bacteraemia in children 
younger than 2 years living in the same community is 
1080 per 100 000 person years,3 which suggests that the 
incidence rate ratio for acquisition of bacteraemia in 
hospital compared with in the community is about 40. The 
rate of nosocomial bacteraemia was higher than at baseline 
(day 2–7) in the second week (relative risk [RR] 1·61, 95% CI 
1·16–2·23) and third week (1·77, 1·18–2·66) of hospital 
stays but not thereafter. The rate of nosocomial bacteraemia 
increased progressively throughout the study from 0·59 per 
1000 person-days (95% CI 0·44–0·78) in 2002–04, to 
1·66 per 1000 person-days (1·34–2·04) in 2008–09. The 
number of blood samples for culture taken more than 48 h 
after admission increased progressively from 163 in 2003, 
to 408 in 2008, with an annual increase of 19% (17–22%). 
Duration of hospital stay also increased throughout the 
study period. The average annual increase in duration of 
admissions was 3·8% (3·3–4·4%); the median duration 
was 3·15 days (IQR 1·90–5·92) in 2002 and 3·98 days 
(2·06–7·96) in 2009. We recorded no diﬀ erence in this 
trend when the analysis was restricted to children who 
survived to discharge. The probability of detection of 
nosocomial bacteraemia when blood samples were taken 
more than 48 h after admission increased slightly during 
the study (RR per year=1·07, 95% CI 1·00–1·14).
Table 1 shows the distribution of children with 
nosocomial bacteraemia by each risk factor, together with 
univariable hazard ratios (HRs). Notably, nosocomial 
bacteraemia was not associated with age group (p=0·18). A 
multivariable proportional hazards model showed 
signiﬁ cant eﬀ ects for nutritional status deﬁ ned in terms of 
weight-for-age Z score, prescription of a blood transfusion, 
and study period. We recorded a signiﬁ cant interaction 
between transfusion and severe anaemia. To elucidate the 
factors behind this interaction, we re-examined the 
multivariable model in two exclusive age strata, patients 
aged 28 days or younger (neonates), and patients older 
than 28 days (infants and children). The pattern of risk 
factors diﬀ ered suﬃ  ciently between these strata to justify 
separate presentation of the results (table 2). Severe 
anaemia and blood transfusion were not risk factors for 
nosocomial bacteraemia in neonates. In infants and 
children, blood transfusion (as prescribed at admission) 
was a highly signiﬁ cant risk factor for nosocomial 
bacteraemia, but only in children who did not have severe 
anaemia (table 2). Poor nutritional status was a risk factor 
at all ages but it showed a more pronounced association in 
neonates than in infants and children (table 2).
In 197 patients who developed one or more episodes 
of nosocomial bacteraemia, the case-fatality rate was 53% 
(105 of 197; 95% CI 46–60), compared with 24% 
(372 of 1528; 22–26) in patients with community-acquired 
Number of admissions 
(% of all admissions)
Outcome 
events
Univariable hazard ratio 
(95% CI)
Age group
0–28 days 4668 (14%) 53 1·38 (0·97–1·94)
29–59 days 1056 (3%) 6 1·18 (0·46–3·00)
60–365 days 8275 (25%) 49 1·40 (0·97–2·01)
Older than 366 days 19 189 (58%) 104 1·0
Sex
Female 14 552 (44%) 97 1·0
Male 18 636 (54%) 115 0·98 (0·74–1·31)
Nutritional status (WAZ)
>–3 26 050 (79%) 78 1·0
–3 to –4 4179 (13%) 52 2·06 (1·42–2·99)
<–4 2692 (8%) 77 2·52 (1·79–3·57)
Missing 267 (1%) 5 3·52 (1·20–10·29)
HIV status
Known negative 8150 (25%) 71 1·0
Known positive 696 (2%) 20 1·60 (0·97–2·66)
Unknown 24 342 (73%) 121 0·67 (0·49–0·92)
Transfusion prescribed
No 30 563 (92%) 153 1·0
Yes 2573 (8%) 58 2·73 (1·98–3·76)
Unknown 52 (<1%) 1 3·90 (0·53–28·7)
Severe malaria*
No 30 205 (91%) 208 1·0
Yes 2789 (9%) 4 0·45 (0·13–1·51)
Severe anaemia†
No 30 132 (91%) 189 1·0
Yes 2167 (7%) 11 0·75 (0·40–1·43)
Unknown or not tested 889 (3%) 12 2·00 (0·97–4·14)
Burns on admission
No 32 724 (99%) 202 1·0
Yes 464 (1%) 10 0·81 (0·41–1·60)
Time admitted
2002–04 13 300 (40%) 48 1·0
2005–07 12 998 (39%) 78 1·58 (1·07–2·32)
2008–09 6890 (21%) 86 2·53 (1·74–3·68)
Total
All admissions 33 188 (100%) 212 ··
WAZ=weight-for-age Z score. *Deﬁ ned as per WHO criteria16 for clinically severe malaria. †Deﬁ ned as haemoglobin 
<50 g/L (for patients older than 28 days) or haemoglobin <90 g/L (for neonates).
Table 1: Risk factors in study patients and univariable hazard ratios
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bacteraemia and 6·2% (1930 of 31 347; 5·9–6·4) in 
patients with no detected episodes of bacteraemia in this 
period. The median interval from sample collection to 
death for patients with nosocomial bacteraemia was 44 h 
(IQR 17–120 h). During the study, 4·3% (105 of 2423) of 
all hospital inpatient deaths occurred in patients in whom 
nosocomial bacteraemia was identiﬁ ed.
89 patients developed nosocomial bacteraemia and 
survived to discharge; the median length of hospital stay 
for these patients was 28·9 days (IQR 13·0–41·6). In 
353 matched patients without nosocomial bacteraemia, 
whose hospital stay lasted at least as long as the time 
when bacteraemia developed in the index child, the 
median duration was signiﬁ cantly shorter (18·8 days; 
8·1–30·9; diﬀ erence between medians 10·1 days, 
p=0·006). Three patients with nosocomial bacteraemia 
were transferred to other facilities, and their eventual 
outcome is unknown.
Gram-negative organisms caused 74% of episodes of 
nosocomial bacteraemia (table 3); Escherichia coli and 
Klebsiella pneumoniae accounted for 21% and 20% of all 
episodes, respectively. Gram-positive organisms, of 
which Staphylococcus aureus was the most common, 
accounted for 21% of cases. Yeasts accounted for 5% of 
episodes of nosocomial bloodstream infection. Health-
care-associated (readmission after recent discharge) 
pathogens were much the same as those causing 
community-acquired bacteraemia.
In patients with nosocomial bacteraemia the case-
fatality rate varied signiﬁ cantly by organism class (χ² test 
p=0·023), being 61% in Gram-negative infections, 38% 
in Gram-positive infections, and 45% in fungal 
infections. Case-fatality rates were highest in patients 
infected with Acinetobacter spp (74%), Pseudomonas 
aeruginosa (75%), and E coli (77%). We detected no 
evidence of increased mortality in patients with isolates 
considered to be contaminants compared with all other 
patients (χ² test p=0·49).
Discussion
Our large study provides a comprehensive description of 
the epidemiology and microbiological causes of noso-
comial bacteraemia in a representative paediatric service 
in sub-Saharan Africa. With a conventional case 
deﬁ nition,17 the risk of nosocomial bacteraemia was 
5·9 per 1000 admissions. This ﬁ nding is consistent with 
a risk of 5·0 per 1000 admissions recorded in a study in 
South Africa in 1989,18 although the cutoﬀ  used to 
deﬁ ne infections as nosocomial in that study was 72 h 
after admission rather than 48 h as we used. The risk 
of nosocomial bacteraemia increased signiﬁ cantly 
throughout the study, which could be attributable, in 
part, to increased length of hospital stay in the later years 
of the study. This increase in turn is probably attributable 
to declining numbers of short admissions for malaria19 
and an increasing proportion of neonatal admissions. 
These factors suggest that the 2008–09 nosocomial 
Age younger than 28 days* 
(HR [95% CI])
Age older than 28 days 
(HR [95% CI])
Nutritional status (WAZ)
>–3 1·00 1·00
 –3 to –4 1·73 (0·71–4·23) 1·99 (1·31–3·04)
<–4 3·40 (1·60–7·26) 1·95 (1·29–2·97)
Missing 5·22 (0·93–29·4) 1·78 (0·42–7·48)
Severe anaemia and transfusion
No severe anaemia, not transfused ·· 1·00
Severe anaemia, not transfused ·· 1·04 (0·33–3·26)
No severe anaemia, transfused ·· 4·99 (3·39–7·37)
Severe anaemia, transfused ·· 0·62 (0·23–1·66)†
Time admitted 
2002–04 1·00 1·00
2005–07 1·87 (0·73–4·82) 1·43 (0·93–2·20)
2008–09 2·34 (0·89–6·14) 2·01 (1·29–3·12)
Severe anaemia and receipt of a blood transfusion had no signiﬁ cant eﬀ ect in neonates and were not included in this 
model for this age group. WAZ=weight-for-age Z score. HR=hazard ratio. *Patients with missing data for blood 
transfusion or anaemia status on admission were excluded from this analysis.†Likelihood ratio test for inclusion of 
interaction term has p=0·015.
Table 2: Risk factors for nosocomial bacteraemia analysed with multivariable Cox regression models
Nosocomial 
(total [%])
Health-care-
associated* 
(total [%])
Community-
acquired
(total [%])
Gram-negative organisms
Escherichia coli 44 (21%) 16 (11%) 144 (9%)
Proteus mirabilis 3 (1%) 1 (1%) 6 (<1%)
Klebsiella pneumoniae 43 (20%) 2 (1%) 37 (2%)
Klebsiella spp (other) 9 (4%) 1 (1%) 5 (<1%)
Pseudomonas aeruginosa 16 (8%) 8 (6%) 31 (2%)
Pseudomonas spp (other) 3 (1%) 1 (1%) 24 (2%)
Acinetobacter spp 19 (9%) 12 (9%) 159 (10%)
Non-typhi Salmonella spp 3 (1%) 10 (7%) 136 (9%)
Salmonella typhi 2 (1%) 0 (0%) 12 (1%)
Other enterobacteriaceae 8 (4%) 4 (3%) 26 (2%)
Haemophilus inﬂ uenzae 2 (1%) 4 (3%) 99 (6%)
Other Gram-negative organisms 4 (2%) 0 (0%) 59 (4%)
Gram-positive organisms
Staphylococcus aureus 20 (9%) 22 (16%) 198 (13%)
Streptococcus pneumoniae 3 (1%) 23 (16%) 459 (29%)
Group A streptococci 1 (1%) 5 (4%) 71 (5%)
Group B streptococci 2 (1%) 18 (13%) 26 (2%)
Group D streptococci 18 (9%) 12 (9%) 53 (3%)
Other gram-positive organisms 1 (1%) 2 (1%) 37 (2%)
Fungi
Yeasts 11 (5%) 1 (1%) 8 (1%)
Total pathogens† 212 (100%) 141 (100%) 1590 (100%)
Data are number of episodes. *Health-care-associated infection was deﬁ ned as bacteraemia within the ﬁ rst 48 h of 
admission to hospital when within 28 days of discharge from hospital or hospital birth. †Contaminants were grown 
from 19·5% of samples collected in the ﬁ rst 48 h after admission and 18·1% of samples obtained 48 h or more after 
admission. These proportions did not diﬀ er signiﬁ cantly (p=0·11).
Table 3: Pathogens causing paediatric bacteraemia in Kiliﬁ  District Hospital, 2002–09
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bacteraemia rate (1·66 per 1000 days in hospital) is a 
better estimate of the present rate in Kiliﬁ  District 
Hospital than the study mean (1·00 per 1000 days in 
hospital). The eﬀ ect of admission is clear from the fact 
that the incidence of nosocomial bacteraemia was about 
40 times greater than the previously estimated incidence 
of community-acquired bacteraemia.3
Nosocomial bacteraemia is associated with high 
mortality; more than half of all patients (53%) died in 
hospital. Particular pathogens (such as P aeruginosa and 
E coli) were associated with very high case-fatality rates. 
Although other factors might have contributed to the risk 
of both bacteraemia and death, such as nutritional status, 
the case-fatality rate for nosocomial bacteraemia was 
more than double that for community-acquired 
bacteraemia (24%). The interval between detection of 
nosocomial bacteraemia and death (median 44 h) means 
that in many cases bacteraemia could have been the 
cause of death. The crude mortality of paediatric 
nosocomial bacteraemia at 49 hospitals in the USA 
between 1995 and 2001 was 14%.20 At Kiliﬁ  District 
Hospital, survivors of nosocomial bacteraemia had a 
substantial morbidity burden, leading to an additional 
10·1 days in hospital per case.
The factor most strongly associated with nosocomial 
bacteraemia in our study was prescription of blood 
transfusion, though this association was conﬁ ned to 
children who did not have severe anaemia. We assume 
that most children prescribed transfusions at admission 
subsequently received the same, although data were not 
collected on the actual administration of transfusions. 
Overall, 2% (52 of 2573) of transfusion recipients 
subsequently developed nosocomial bacteraemia, which 
is similar to a rate of 3·5% of post-transfusion bacteraemia 
recorded in Malawi.21 In African hospitals, clinicians 
often use blood transfusions to resuscitate shocked 
patients and for treatment of severe anaemia. In this 
study, 55% of patients prescribed a transfusion were 
severely anaemic (1408 of 2573), 27% (689 of 2573) were 
clinically shocked (as per WHO criteria), and 33% were 
neither severely anaemic nor shocked (847 of 2573). One 
possible explanation for the association of bacter aemia 
with transfusion is that these nosocomial infections 
were, in fact, delayed detection of community-acquired 
septicaemic shock. A second possible explan ation for the 
reported association is contamination of blood for 
transfusion. In a study in Mombasa, Kenya, 8% of blood 
packs in the transfusion service had bacterial contamin-
ation.22 The absence of transfusion-associated risk in 
severely anaemic patients argues against this inter-
pretation. However, the combination of a strong 
association in patients without severe anaemia and local 
evidence of blood contamination supports a critical 
assessment of the role of blood transfusion in nosocomial 
bacteraemia in Africa.23
Malnutrition was a risk factor for nosocomial bacter-
aemia at all ages. This ﬁ nding is consistent with studies 
of both community-acquired bacteraemia24 and late 
hospital mortality in the region.25 Other factors previously 
identiﬁ ed as risks for bacteraemia in general are (neonatal) 
age,8 HIV infection, and anaemia.26 That HIV infection 
was not signiﬁ cant in the multivariable model is indicative 
of underascertainment of HIV status in our study 
population—more than 70% of patients were of unknown 
HIV status because universal HIV testing was not 
implemented in Kiliﬁ  District Hospital until 2008. 
Furthermore, some of the risk of HIV infection might 
be indicated through nutritional status. Unexpectedly, 
patients with unknown HIV status seemed to be at 
decreased risk of disease in the univariable analysis—this 
ﬁ nding is largely attributable to the confounding eﬀ ect of 
the time period. Anaemia was not a risk factor after the 
eﬀ ects of blood transfusion had been incorporated in the 
model, though, notably, children admitted to Kiliﬁ  District 
Hospital are much more anaemic than the general 
population.27 No data were available for peripheral intra-
venous catheter use, which is likely to be an important 
risk factor in paediatric nosocomial bacteraemia.20
Our study might have underestimated the true risk of 
nosocomial bacteraemia for two reasons. First, the 
sensitivity of paediatric blood cultures is inherently poor, 
especially when antibiotic use is common and only one 
small-volume culture is collected.3 Second, not all 
children who deteriorate in Kiliﬁ  District Hospital are 
investigated with blood cultures. For example, blood for 
culture was obtained during the 48 h before death from 
less than 50% of children dying in hospital. Even if only 
10% of these children had had hospital-acquired 
bacteraemia, the calculated risk of nosocomial bacter-
aemia would have doubled.
We used a standard 48 h cutoﬀ  to separate hospital 
and community acquisition, which might have mis-
classiﬁ ed some community-acquired infections as 
hospital-acquired. The low sensitivity of blood cultures3 
Panel: Research in context
Systematic review
A systematic review by WHO in 2010 identiﬁ ed no reports 
about paediatric or adult nosocomial bacteraemia in African 
countries between 1995 and 2008.7 We searched PubMed 
using the MeSH terms (“nosocomial” OR “hospital-acquired”) 
AND (“bacteraemia” OR “septicaemia”) AND (Africa) in 
July, 2011, and found no subsequent studies of relevance.
Interpretation
As far as we are aware, our study is the only recent description 
of hospital-acquired paediatric bacteraemia in sub-Saharan 
Africa, other than outbreak reports. Although this form of 
disease is rare, it has serious eﬀ ects on morbidity and 
mortality, and the microbiological causes are distinct from 
those of community-acquired bacteraemia. Malnutrition is a 
risk factor for hospital acquired bacteraemia.
Articles
2026 www.thelancet.com   Vol 378   December 10, 2011
increasingly apparent and an eﬀ ective response from 
doctors, nurses, hospital managers, and policy makers 
will be essential.
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